2.2 – Medical technologies

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767162.

Pillar 2: Innovative industry for citizens

Session 2.2 – Medical technologies

30 October 2018, 14:30-15:30, room STRAUSS 2


The medical technology industry and the nanomedicine field are important economic and social players in Europe. The session will provide insights and examples about how to overcome current challenges, demonstrating medical devices in relevant industrial environments and facilitating the development of new and safe medical technologies. A specific interest will be on the impact of the new EU regulatory frame for medical devices. Attention will also be paid to aspects related to how Test Beds should make design, development, testing, safety assessment and upscaling of new/existing medical device services available to industry in compliance with EU regulatory frameworks, as well as how technologies can help to increase the quality and speed of medical treatments without increasing costs for society.


Please find below the speakers (in alphabetical order), who will contribute to this session:

  • Innovative medical technology solutions for sustainable and equitable health for all
    Patrick Boisseau, CEA
  • Biomimetic strategy for bone regeneration
    Oskar Hoffmann, University of Vienna
  • Cost-effective micro-structuring technologies for devices aimed to improve clinical diagnostics
    Anneliese Pönninger, EV Group E. Thallner Gmbh
  • Nanomedicine driving the new collaborative business model of smart and connected medical devices
    Klaus-Michael Weltring, Nanobioanalytic Muenster, ETP Nanomedicine

Moderator: Klaus-Michael Weltring, Nanobioanalytic Muenster, ETP Nanomedicine

Rapporteur: Wim Cuypers

Patrick Boisseau

VP Healthtech
CEATech

Oskar Hoffmann

University of Vienna

Anneliese Pönninger

Business Development Manager
EV Group

Klaus-Michael Weltring

Managing Director
Bioanalytik Münster e. V.